-
- 抗原 See all CCL9 (Ccl9) 抗体
- CCL9 (Ccl9) (Chemokine (C-C Motif) Ligand 9 (Ccl9))
-
抗原表位
- AA 22-122
-
适用
- 小鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This CCL9 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
- 特异性
- The antibody is a rabbit polyclonal antibody raised against MIP1g. It has been selected for its ability to recognize MIP1g in immunohistochemical staining and western blotting.
- 纯化方法
- Antigen-specific affinity chromatography
- 免疫原
- MIP1g (Gln22-Gln122)
- 亚型
- IgG
- Top Product
- Discover our top product Ccl9 Primary Antibody
-
anti-Chemokine (C-C Motif) Ligand 9 (Ccl9) (AA 22-122) antibody
Ccl9 适用: 小鼠 ELISA, IF (cc), IF (p), IHC (fro), IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Chemokine (C-C Motif) Ligand 9 (Ccl9) (AA 27-117) antibodyCcl9 适用: 大鼠 WB, IHC, ICC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
- Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.
- 说明
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% Glycerol
-
- 抗原
- CCL9 (Ccl9) (Chemokine (C-C Motif) Ligand 9 (Ccl9))
- 别名
- Macrophage Inflammatory Protein 1 Gamma (MIP1g) (Ccl9 产品)
- 别名
- CCF18 antibody, MRP-2 antibody, Scya10 antibody, Scya9 antibody, chemokine (C-C motif) ligand 9 antibody, Ccl9 antibody
- 背景
- Alternative Names: CCL9, CCL10, SCYB9, CCF18, MRP2, C-C motif chemokine 9, Macrophage inflammatory protein-related protein 2, Small-inducible cytokine A9
-
You are here:
